Eurican DAPPi inj. susp. (lyoph. + solv.) s.c. vial

Țară: Belgia

Limbă: engleză

Sursă: AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

Cumpara asta acum

Ingredient activ:

Canine Distemper Virus (live, attenuated) ; Canine Parvovirus (live, attenuated) ; Canine Parainfluenzavirus (live, attenuated) ; Canine Adenovirus 2 (live, attenuated)

Disponibil de la:

Boehringer Ingelheim Animal Health Belgium SA-NV

Codul ATC:

QI07AD04

INN (nume internaţional):

Canine Distemper Virus (CDV); Canine Adenovirus Type 2; Canine Parainfluenza Virus Type 2; Canine Parvovirus Type 2

Forma farmaceutică:

Lyophilisate and solvent for suspension for injection

Compoziție:

Canine Distemper Virus (CDV); Canine Adenovirus Type 2; Canine Parainfluenza Virus Type 2; Canine Parvovirus Type 2

Calea de administrare:

Subcutaneous use

Grupul Terapeutică:

dog

Zonă Terapeutică:

Canine Distemper Virus + Canine Adenovirus + Canine Parvovirus + Canine Parainfluenza Virus

Rezumat produs:

CTI code: 499164-01 - Pack size: 10 x 1 dose + 10 x 1 ml - Commercialisation status: YES - FMD code: 03661103053583 - CNK code: 3495033 - Delivery mode: Medical prescription; CTI code: 499164-03 - Pack size: 100 x 1 ml + 100 x 1 dose - Commercialisation status: NO - Delivery mode: Medical prescription; CTI code: 499164-02 - Pack size: 50 x 1 dose + 50 x 1 ml - Commercialisation status: NO - Delivery mode: Medical prescription

Statutul autorizaţiei:

Commercialised: Yes

Data de autorizare:

2016-07-04

Documente în alte limbi

Prospect Prospect germană 01-07-2022
Prospect Prospect franceză 01-07-2022
Caracteristicilor produsului Caracteristicilor produsului franceză 01-07-2022
Prospect Prospect olandeză 01-07-2022
Caracteristicilor produsului Caracteristicilor produsului olandeză 01-07-2022